![>](style_images/Executiv-909/nav_m.gif)
Merck considers appeal of MS drug rejection
Health / Medicine Related News
The German pharmaceutical group says it may appeal the decision by European regulators on its new multiple sclerosis treatment cladribine, also known by its brand name Movectro
Source: FT.com - Pharmaceuticals